Pacific Wealth Management’s Halozyme HALO Stock Holding History

Pacific Wealth Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$349K	Buy	+5,401	New	+$381K	0.19%	13

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pacific Wealth Management's HALO Position: Q1 2026 in Review

Pacific Wealth Management opened a new position in Halozyme (HALO) in Q1 2026: 5,401 shares worth $349K. The stake represents 0.19% of the portfolio and ranks #13 among its holdings.

635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

Pacific Wealth Management held 5,401 shares of Halozyme worth $349K as of Q1 2026.
Halozyme was a new Pacific Wealth Management position in Q1 2026.
Halozyme made up 0.19% of Pacific Wealth Management's portfolio in Q1 2026, its #13 holding.
635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Pacific Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.